Urine Test for Bladder Cancer
October 22, 2019 | Terry Sharrer
From a collaboration between cancer researchers at Georgetown University and Fudan University, this piece explains how a “conditional reprogramming” cell culture, which introduces a Rho kinase inhibitor, allows bladder cancer cells collected in a urine sample to grow indefinitely. This is the first step in sorting out a tumor’s heterogeneity and determining the most effective drug for treating an individual’s cancer. Thus, a urine test could be preferable to a liquid biopsy. MORE
Image Credit: Georgetown University and Fudan University